Gabapentin Tablet
Product Images NDC 63629-3063

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 63629-3063). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1

A line graph showing mean pain scores over an 8-week period comparing placebo and Gabapentin 3600 mg/day. The x-axis represents weeks from baseline to week 8, and the y-axis shows mean pain scores from 0 to 10. The graph highlights a 4-week dose titration period followed by a 4-week fixed dose period, with the Gabapentin group showing a decline in pain scores over time compared to placebo.*

FDA Label Image

Figure2

A line graph showing mean pain scores over a 7-week period comparing placebo and Gabapentin at doses of 1800 mg/day and 2400 mg/day. The x-axis represents weeks from baseline through week 7, while the y-axis shows mean pain score values. The graph is divided into a 3-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

Figure3

A bar chart titled "Proportion of Responders (patients with > 50% reduction in pain score) at Endpoint: Controlled PHN Studies". It compares placebo (PBO) and gabapentin (GBP) groups in two studies, showing higher responder rates for gabapentin 3600 mg in Study 1 and gabapentin 1800 mg and 2400 mg in Study 2, with significance markers for p < 0.01 and p < 0.001.*

FDA Label Image

Figure4

A scatter plot illustrating the percentage difference as a function of daily Gabapentin dose in milligrams. The chart compares results from three studies labeled as a, b, and c, with study a shown in black squares, study b in gray squares, and study c in white squares. The x-axis represents daily doses from 600 mg to 1800 mg, and the y-axis shows the percentage difference ranging from 2% to 22%.*

FDA Label Image

Logo (Logo)

FDA Label Image

Structure (Structure)

Chemical structure of gabapentin, showing its cyclic and functional groups as part of its molecular composition.*

FDA Label Image

Equation (Equation)

A formula for calculating creatinine clearance (CLCr), including variables for age, weight, serum creatinine, and an adjustment factor for female patients. The image is a text panel showing this medical calculation equation.*

FDA Label Image

Label Image (Lbl636293063)

Gabapentin 600 mg tablet label from Bryant Ranch Prepack. The label includes a comparison to Neurontin 600 mg tablets by Glenmark Pharmaceuticals. It displays storage instructions (20°-25°C), a warning that the drug may cause dizziness, and a note to keep all drugs out of reach of children. The package size is 30 tablets, with NDC 63629-3063 and a barcode present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.